Invention Grant
- Patent Title: Mineralocorticoid receptor antagonists and methods of use
- Patent Title (中): 盐皮质激素受体拮抗剂及其使用方法
-
Application No.: US12330539Application Date: 2008-12-09
-
Publication No.: US07994164B2Publication Date: 2011-08-09
- Inventor: Konstantinos Gavardinas , Prabhakar Kondaji Jadhav
- Applicant: Konstantinos Gavardinas , Prabhakar Kondaji Jadhav
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Francis O. Ginah; Alexander Wilson
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D413/14
Abstract:
The present invention provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart failure, hypertension, diabetic nephropathy, or chronic kidney disease, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20090163472A1 MINERALOCORTICOID RECEPTOR ANTAGONISTS AND METHODS OF USE Public/Granted day:2009-06-25
Information query
